AMGXF
Price
$0.36
Change
-$0.05 (-12.20%)
Updated
Dec 5 closing price
Capitalization
159.13M
CSBR
Price
$6.89
Change
+$0.39 (+6.00%)
Updated
Jun 6 closing price
Capitalization
89.25M
39 days until earnings call
Interact to see
Advertisement

AMGXF vs CSBR

Header iconAMGXF vs CSBR Comparison
Open Charts AMGXF vs CSBRBanner chart's image
AnGes MG
Price$0.36
Change-$0.05 (-12.20%)
Volume$2.05K
Capitalization159.13M
Champions Oncology
Price$6.89
Change+$0.39 (+6.00%)
Volume$11.54K
Capitalization89.25M
AMGXF vs CSBR Comparison Chart
Loading...
CSBR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMGXF vs. CSBR commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGXF is a Hold and CSBR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (AMGXF: $0.36 vs. CSBR: $5.98)
Brand notoriety: AMGXF and CSBR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMGXF: 100% vs. CSBR: 15%
Market capitalization -- AMGXF: $159.13M vs. CSBR: $89.25M
AMGXF [@Biotechnology] is valued at $159.13M. CSBR’s [@Biotechnology] market capitalization is $89.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGXF’s FA Score shows that 0 FA rating(s) are green whileCSBR’s FA Score has 1 green FA rating(s).

  • AMGXF’s FA Score: 0 green, 5 red.
  • CSBR’s FA Score: 1 green, 4 red.
According to our system of comparison, CSBR is a better buy in the long-term than AMGXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSBR’s TA Score shows that 5 TA indicator(s) are bullish.

  • CSBR’s TA Score: 5 bullish, 3 bearish.

Price Growth

AMGXF (@Biotechnology) experienced а 0.00% price change this week, while CSBR (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CSBR is expected to report earnings on Jul 17, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMGXF($159M) has a higher market cap than CSBR($89.3M). AMGXF YTD gains are higher at: 0.000 vs. CSBR (-30.222).
AMGXFCSBRAMGXF / CSBR
Capitalization159M89.3M178%
EBITDAN/A8.43M-
Gain YTD0.000-30.222-
P/E RatioN/A14.34-
RevenueN/A58.6M-
Total CashN/A3.2M-
Total DebtN/A6.44M-
FUNDAMENTALS RATINGS
AMGXF vs CSBR: Fundamental Ratings
AMGXF
CSBR
OUTLOOK RATING
1..100
3655
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9610
PRICE GROWTH RATING
1..100
5763
P/E GROWTH RATING
1..100
10089
SEASONALITY SCORE
1..100
3085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGXF's Valuation (62) in the null industry is in the same range as CSBR (81) in the Biotechnology industry. This means that AMGXF’s stock grew similarly to CSBR’s over the last 12 months.

AMGXF's Profit vs Risk Rating (100) in the null industry is in the same range as CSBR (100) in the Biotechnology industry. This means that AMGXF’s stock grew similarly to CSBR’s over the last 12 months.

CSBR's SMR Rating (10) in the Biotechnology industry is significantly better than the same rating for AMGXF (96) in the null industry. This means that CSBR’s stock grew significantly faster than AMGXF’s over the last 12 months.

AMGXF's Price Growth Rating (57) in the null industry is in the same range as CSBR (63) in the Biotechnology industry. This means that AMGXF’s stock grew similarly to CSBR’s over the last 12 months.

CSBR's P/E Growth Rating (89) in the Biotechnology industry is in the same range as AMGXF (100) in the null industry. This means that CSBR’s stock grew similarly to AMGXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSBR
RSI
ODDS (%)
Bullish Trend 12 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
78%
Momentum
ODDS (%)
Bearish Trend 12 days ago
85%
MACD
ODDS (%)
Bullish Trend 12 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
79%
Advances
ODDS (%)
Bullish Trend 26 days ago
73%
Declines
ODDS (%)
Bearish Trend 18 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
76%
Aroon
ODDS (%)
Bearish Trend 12 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CSBR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AMGXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGXF has been loosely correlated with EWTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGXF jumps, then EWTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGXF
1D Price
Change %
AMGXF100%
N/A
EWTX - AMGXF
35%
Loosely correlated
-2.34%
APLT - AMGXF
32%
Poorly correlated
-1.75%
PRTG - AMGXF
28%
Poorly correlated
+0.63%
XCUR - AMGXF
27%
Poorly correlated
-0.10%
CSBR - AMGXF
23%
Poorly correlated
-0.17%
More

CSBR and

Correlation & Price change

A.I.dvisor tells us that CSBR and LIXT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBR and LIXT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSBR
1D Price
Change %
CSBR100%
-0.17%
LIXT - CSBR
25%
Poorly correlated
+0.75%
PYPD - CSBR
24%
Poorly correlated
-0.39%
INZY - CSBR
23%
Poorly correlated
N/A
PMN - CSBR
23%
Poorly correlated
-10.13%
AMGXF - CSBR
23%
Poorly correlated
N/A
More